Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:p>On the western border of Thailand, <jats:italic>Plasmodium falciparum</jats:italic> has become resistant to almost all antimalarial agents. The molecular basis of resistance in these parasite populations has not been well characterized. This study assessed genetic polymorphisms in the <jats:italic>pfmdr1</jats:italic> gene in 54 parasites collected from the western border of Thailand to determine the relationship of<jats:italic>pfmdr1</jats:italic> copy number and codon mutations with parasite sensitivities to mefloquine, chloroquine, halofantrine, quinine, and artesunate assessed in vitro. A point mutation at codon 86 (resulting in a change of Asn to Tyr) was associated with a significantly lower 50% inhibitory concentration (IC<jats:sub>50</jats:sub>) of mefloquine (median, 9 ng/ml versus 52.4 ng/ml; <jats:italic>P</jats:italic> = 0.003). Overall 35% of the isolates (19 of 54) had an increase in <jats:italic>pfmdr1</jats:italic> copy number, and all 19 carried the wild-type allele at codon 86. Increased<jats:italic>pfmdr1</jats:italic> copy number was associated with higher IC<jats:sub>50</jats:sub>s of mefloquine (<jats:italic>P</jats:italic> = 0.04) and artesunate (<jats:italic>P</jats:italic> = 0.005), independent of polymorphism at codon 86. The relationship between <jats:italic>pfmdr1</jats:italic> and resistance to structurally distinct antimalarial agents confirms the presence of a true multidrug-resistant phenotype.</jats:p>

Original publication

DOI

10.1128/aac.43.12.2943

Type

Journal article

Journal

Antimicrobial Agents and Chemotherapy

Publisher

American Society for Microbiology

Publication Date

01/12/1999

Volume

43

Pages

2943 - 2949